# Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis

> **NCT06058858** · — · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 250 (estimated)

## Conditions studied

- Cytomegalovirus Infections
- Acute Leukemia
- B Cell Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06058858
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-17
- **Primary completion:** 2025-04-17
- **Final completion:** 2025-04-17
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2024-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06058858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06058858, "Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06058858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*